Everbright Health is a US healthcare technology and services business, operated by Careforce Inc., that helps existing mental-health practices add and manage interventional psychiatry services. Its Activate AI platform supports review of clinical records, identification and outreach to potentially eligible patients, scheduling and payer prior-authorization workflows. The company also provides equipment, technical staffing, operational support, billing and compliance infrastructure for services such as transcranial magnetic stimulation (TMS) and SPRAVATO treatment. Its model embeds these service lines within partner practices, including treatment-resistant depression care, rather than manufacturing a drug or stimulation device. Founded by Ben Kuhn and Ginger Holguin and incubated by W Health Ventures/2070 Health, Everbright announced its launch and seed investment in October2025. Its current public leadership includes a psychiatrist serving as Chief Medical Officer.
